The timetable for access to new drugs in Ireland is “significantly” influenced by decisions made by the pharmaceutical industry, according to Prof Michael Barry, Clinical Director of the National Centre for Pharmacoeconomics (NCPE).
Medicines are often launched in larger European countries before Ireland. Prof Barry highlighted that the HSE has “nothing to do” with the decisions of the pharmaceutical industry.
@mccarthymt7 “When a process is designed to cause delays, and it results in delays”
Lynch Syndrome Ireland 